Trauma-informed care — Building safer, more inclusive services through understanding, dialogue and practice
Date: 04 November 2026, 12:00–13:30 Lisbon time (WET) — 13:00–14:30 (CET).
Objectives
The webinar aims to:
Website
L'Agence européenne des drogues (EUDA) est l'autorité principale en matière de drogues illicites en Europe. Basée à Lisbonne, au Portugal, l'EUDA fournit des preuves et analyses scientifiques indépendantes sur tous les aspects de cette menace en constante évolution, tant pour les individus que pour la société dans son ensemble. L'EUDA contribue aux politiques de l'UE et des États membres afin de protéger les citoyens européens des dangers liés aux drogues. Elle est une agence de l'Union européenne.
Mission
Notre nouvelle mission se concentre sur la contribution à la préparation de l'Union européenne (UE) en matière de drogues par le biais de quatre actions principales : anticiper, alerter, répondre et apprendre.
Related Knowledge Share items
Protecting young people from recruitment into criminal drug networks: Research gaps and priorities for stronger prevention and intervention in the European Union
Safe futures is an initiative supported by the European Union Drugs Agency to strengthen shared understanding of, and responses to, the recruitment and exploitation of young people into criminal drugs networks across Europe. The initiative...
Cannabis and mental health
Objective: This webinar will provide an overview of mental health risks associated with cannabis use. Participants will hear about the findings on how cannabis use is linked to anxiety, depression, psychotic symptoms and cannabis use disorder, and how cannabis type, potency, and use patterns might increase the risks.
European drug situation through institutional and civil society perspectives
Objective: To create an opportunity for civil society organisations (CSOs) and EUDA to exchange views on the current European drug situation and reflect on its implications from institutional, community and civil society perspectives.
Assessment of the threat posed by highly potent synthetic opioids in Europe
This threat assessment examines the potential risks posed by highly potent synthetic opioids (HPSOs) in Europe over the next two years. Drawing on early warning data, forensic and clinical evidence, and expert input, the report explores how...
Preventing opioid-related deaths in Europe — continuity of care, peer naloxone and rapid overdose alerts
Objective: To mark International Overdose Awareness Day on 31 August, this webinar convenes policy, practice, research and community voices to discuss compassionate, evidence-informed and practical actions that can prevent opioid-related deaths across Europe.
Understanding dual disorders
Objective: This webinar will provide an overview of dual disorders (DD), introduce the recently launched EUDA health and social responses miniguide, and offer practical insights from EU-based initiatives. Participants will gain a clearer understanding of the challenges associated with co-occurring mental health and substance use disorders, as well as examples of how these are being addressed in different contexts.
Addressing the recruitment of young people into criminal drugs networks
This report examines how and why young people are recruited into criminal drug networks across Europe. It highlights the range of factors that can increase vulnerability to recruitment, including social and economic disadvantage, peer...
Drug production and precursors — EUDA ongoing activities
The European Union Drugs Agency (EUDA) continues to monitor illicit drug production and precursor chemicals across Europe to improve understanding of how drug markets are evolving. Production within the European Union is primarily focused...
European Drug Report 2026: Trends and Developments
The European Drug Report 2026: Trends and Developments provides the latest overview of the drug situation across Europe, drawing on data from EU Member States, Türkiye, and Norway. The report examines patterns of drug use, drug-related...
